コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nges in adiposity (body mass index (BMI) and waist circumference).
2 fat by computed tomography scan (in lieu of waist circumference).
3 g length and LHR were associated with higher waist circumference.
4 sociated with both body mass index (BMI) and waist circumference.
5 bly associated with change in body weight or waist circumference.
6 ified the effect of SMAD2 rs11082639 on high waist circumference.
7 PUFAs was not associated with 5-y change in waist circumference.
8 UFAs was not associated with a 5-y change in waist circumference.
9 g age, but increased with increasing BMI and waist circumference.
10 more pronounced in individuals with a normal waist circumference.
11 102 cm in men but not in those with a larger waist circumference.
12 ) body mass index (BMI), ponderal index, and waist circumference.
13 Obesity was determined by waist circumference.
14 unidentified imprinted locus associated with waist circumference.
15 nonsignificant after adjustment for BMI and waist circumference.
16 for weight (0.13 lb; 95% CI, 0.11 to 0.15), waist circumference (0.009 inches; 95% CI, 0.004 to 0.01
17 diposity alleles were associated with higher waist circumference (0.454 cm [0.267, 0.641] 50% vs. 50%
19 0.28; 95% CI: -0.42, -0.14; P = 0.0001), and waist circumference (-0.63 cm; 95% CI: -1.11, -0.16 cm;
20 TL: BMI -0.00478 (95% CI -0.00749--0.00206), waist circumference -0.00211 (95% CI -0.00325--0.000969)
21 body-mass index (1.09 [1.01-1.17]; p=0.023), waist circumference (1.13 [1.02-1.26]; p=0.018), basal m
22 reductions in body weight (-0.8 to -1.2 kg), waist circumference (-1.1 to -1.9 cm), and mean arterial
23 igher values of 1.32 (95% CI, 1.25-1.41) for waist circumference, 1.11 (95% CI, 1.08-1.14) for waist/
26 e RFM equation for adults (64 - (20 x height/waist circumference) + (12 x sex)) may be used for adole
27 n of bodyweight (-4.85 [-8.21 to -1.48]) and waist circumference (-3.31 [-5.95 to -0.67]) than partic
28 8 years), body mass index (BMI) (2-8 years), waist circumference (4-8 years), and body fat (8 years).
30 5 trials on percentage body fat, 4 trials on waist circumference, 4 trials on fasting plasma glucose,
32 (-7.6 +/- 0.3 compared with 0.4 +/- 0.5 kg), waist circumference (-6.2 +/- 0.4 compared with 0.9 +/-
33 ger increases were seen in women for BMI and waist circumference (7-8%), but trends in skinfolds were
34 BMI (25.0 [21.2-29.3] vs 23.1 [19.5-27.6]), waist circumference (83.0 [73.5-95.4] vs 79.0 [68.5-91.0
35 o <30 in 38% and >=30 in 30%, 33% had a high waist circumference, 89% were physically inactive, 37% (
36 facilities close to home had 1.22 cm smaller waist circumference (95% CI -1.64 to -0.80), 0.57 kg/m(2
37 l change (Delta) in body weight (BW), WC, or waist circumference adjusted for BMI (WCBMI) and possibl
38 arge meta-analysis of waist-to-hip ratio and waist circumference adjusted for body mass index (BMI),
39 ntal caries and restorations, and obesity by waist circumference (adjusted for snacking and sex).
40 nsus Statement proposes that measurements of waist circumference afford practitioners with an importa
43 inflammatory markers in the blood as well as waist circumference and % body fat were lower post inter
44 ignificant differences in the predicted mean waist circumference and BMI between the low- and high-ex
48 ed with abnormal LV geometry, and increasing waist circumference and body fat were associated with wo
50 les <0.0001] and with further adjustment for waist circumference and body mass index [1.26 (1.07, 1.4
51 had statistically significant higher BMI and waist circumference and consumed more energy, and also h
53 o be stronger for hip circumference than for waist circumference and for fat-free mass than for fat m
54 l within the range associated with differing waist circumference and likely to be relevant to the ass
55 ilarly, fasters had a significantly low mean waist circumference and low mean body fat percent (P < 0
56 me was independently associated with smaller waist circumference and lower BMI and body fat percentag
57 Inverse associations were observed between waist circumference and LTL (-0.96% per z-score unit; 95
61 itional status as risk factors for increased waist circumference and type 2 diabetes among Ghanaian a
63 ngth, leg length-to-height ratio (LHR)] with waist circumference and type 2 diabetes, respectively.
65 ncing BMI and central adiposity, measured as waist circumference and waist-to-hip ratio both adjusted
67 essure), metabolic (HOMA(ir), triglycerides, waist circumference), and immune (white blood cell count
68 ood pressure, 2.1% (95% CI: 0.5, 3.8) higher waist circumference, and 1.6% (95% CI: - 0.6, 3.8) highe
69 increase of both systolic blood pressure and waist circumference, and a reduction in the probability
70 rement may be beneficial for blood pressure, waist circumference, and alcohol consumption in the Chin
71 of dietary pulse consumption on body weight, waist circumference, and body fat by conducting a system
73 ffects of viscous fiber on body weight, BMI, waist circumference, and body fat, independent of calori
75 ibitors and anthropometric measures [height, waist circumference, and body mass index (BMI)] during a
78 ures were associated with lower BMI z-score, waist circumference, and fat mass in boys during early c
80 for age, sex, smoking, LDL-cholesterol, BMI, waist circumference, and HOMA-insulin resistance (HOMA-I
81 a significant reduction in body mass index, waist circumference, and improvement in blood pressure t
82 nts of body mass index, waist-hip ratio, and waist circumference, and information on 5 genetic varian
83 , lower BMI, lower C-reactive protein, lower waist circumference, and lower odds of hypertension and
84 Metabolic parameters, particularly increased waist circumference, and not HIV-specific factors, were
85 We measured child body mass index (BMI), waist circumference, and percent body fat at 8 y of age.
86 Body mass index (weight (kg)/height (m)2), waist circumference, and percent body fat were measured
87 ne the relationship between body mass index, waist circumference, and percent body fat with conventio
88 s inversely associated with body mass index, waist circumference, and percent body fat, while 2,5-dic
89 index (BMI), BMI z score, body composition, waist circumference, and percentage body fat] in childre
90 between 3 fatness measures (body mass index, waist circumference, and percentage of body fat) and the
91 smoking status, frequency of dental visits, waist circumference, and recreational physical activity.
92 outcome measures were changes in bodyweight, waist circumference, and self-reported target behaviours
94 were fairly similar trends in levels of BMI, waist circumference, and skinfold thicknesses in men in
95 ubjects, after adjusting for site, age, sex, waist circumference, and sleep duration (P = 0.06 for et
97 e standard deviation higher body mass index, waist circumference, and waist-hip ratio gave RRs of 1.2
98 en body size (body mass index [BMI], height, waist circumference, and waist-to-hip ratio) and body fa
100 )), body weight, percentage of body fat, and waist circumference] and glucose and insulin metabolism
101 ucose, glycated haemoglobin (HbA1c), weight, waist circumference, anxiety, quality of life, and daily
104 I), a genetic predisposition score including waist circumference-associated single nucleotide polymor
108 s were adjusted for age, sex, ethnicity, and waist circumference at baseline (plus baseline ISI for 1
109 NAcc is related to individual differences in waist circumference at baseline and is predictive of inc
110 ith sedentary time (B = 4.04, P = 0.006) and waist circumference (B = 1.59, P < 0.001), whereas waist
111 ct of birth weight on sedentary time through waist circumference (B: 1.30; 95% bias-corrected CI: 0.9
113 er BMI (beta -0.22 kg/m(2), -0.25 to -0.20), waist circumference (beta -0.54 cm, -0.61 to -0.48), and
114 MI (beta 0.19 kg/m(2), 95% CI 0.14 to 0.24), waist circumference (beta 0.41 cm, 0.28 to 0.54), and wh
115 index (beta = 0.017, 95%CI: -0.026; -0.009), waist circumference (beta = -0.043, 95%CI: -0.061; -0.02
116 95% CI: -0.60, -0.13) at 2-8 years, smaller waist circumference (beta = -1.81 cm; 95% CI: -3.13, -0.
117 95% CI: -2.91, -0.34, n = 142), and smaller waist circumference (beta = -2.02; 95% CI: -3.71, -0.32,
118 49; 95% CI 1.30-4.77), a steeper increase of waist circumference (beta=2.41; 95% CI 1.19-3.63) and in
120 SD) age = 16.8 (0.2) years), height, weight, waist circumference, blood lipids, glucose, insulin, and
121 tering patients and was associated with BMI, waist circumference, blood pressure, heart rate, HbA1c,
122 fter adjustments for age, service specialty, waist circumference, body mass index, alcohol consumptio
124 ic blood pressure, diastolic blood pressure, waist circumference, body mass index, smoking status, an
126 ty to fast-food outlets were associated with waist circumference, body-mass index (BMI), and body fat
128 dence that clinically relevant reductions in waist circumference can be achieved by routine, moderate
129 adiposity (body weight, body mass index, or waist circumference), cases of T2D, cases of cardiovascu
130 index z score (2.0 versus 1.6, P < 0.0001), waist circumference centile (96th versus 90th, P < 0.000
132 ith suppressed HIV-1 RNA examined weight and waist circumference change before and after first switch
133 rther accounting for body mass index change, waist circumference change, or respective abdominal adip
134 ndicators of body-mass index (BMI; kg/m(2)), waist circumference (cm), whole body fat (kg), and obesi
136 concentrations as well as blood pressure and waist circumference did not differ significantly between
138 eline and 12 and 24 mo included body weight, waist circumference, fat mass (FM), fat-free mass (FFM),
140 t height, body composition (body-mass index, waist circumference, fat, and lean mass), and cardiometa
141 and their accretion in infancy with height, waist circumference, FM, FFM, and cardiometabolic risk m
143 cg08309687 in chromosome 21 associated with waist circumference for the first time (P = 2.24 x 10(-7
145 paring the fourth with the first quartile of waist circumference gave an RR of 1.95 (95% CI = 1.46-2.
146 ary outcomes were gastrointestinal symptoms, waist circumference, glycemic status, and changes in the
148 ity such as body mass index >/= 30 kg/m(2) , waist circumference >/=102 cm or increased parietal wall
149 ATS receiving gender-affirming treatment had waist circumference >102 cm (compared with <=25% in othe
150 ts with type 2 diabetes aged >18 years, with waist circumference >94 (males) or >80 (females) cm, ser
151 y) with body mass index (in kg/m(2)) >29 and waist circumference >98 cm were randomly assigned to a v
152 presence of >=3 of the following components: waist circumference >=102 cm for males or >=88 cm for fe
153 e (controlling for chronologic age) included waist circumference (>88 vs <=88 cm) (odds ratio [OR], 1
154 fat = 14.1 +/- 2.7%-TEI) intakes as regards waist circumference, HDL-C, blood pressure, glucose, ins
155 lycerides, fasting glucose, body mass index, waist circumference, heart rate (HR) and diabetes, but w
156 mposite of seven biomarkers [blood pressure, waist circumference, hemoglobin A1c (HbA1c), insulin res
157 ifestyle factors, body mass index (BMI), and waist circumference, higher omentin concentrations were
159 -shaped association, whereas height, weight, waist circumference, hip circumference, fat mass, and fa
160 = 1.35, 95%CI: 1.13-1.61; Ptrend < 0.0001), waist circumference (HR = 1.66, 95%CI: 1.39-1.99; Ptrend
162 er adjusting for body mass index in kg/m(2), waist circumference, hypertension, dyslipidemia, diabete
163 than 2 of the following 4 criteria (elevated waist circumference, hypertension, elevated plasma gluco
166 20)), type 2 diabetes (P=2.8 x 10(-13)), hip/waist circumference in men (P=1.1 x 10(-9)), schizophren
167 eption and body weight, body mass index, and waist circumference in older subjects with MetS and iden
169 professional societies to routinely include waist circumference in the evaluation and management of
170 ased adiposity (1.26 kg/m(2) BMI and 3.58 cm waist circumference increase, p < 0.0001), circulating i
172 were similar if adjustment was performed for waist circumference instead of BMI or if additional adju
173 as since been validated in many studies, and waist circumference is now a criterion for the diagnosis
174 s associated with adolescent age, and higher waist circumference, levels of alanine or aspartate amin
175 +/- 1.56; HF: 2.97 +/- 1.02; P = 0.029) and waist circumference (LF: 9.36 +/- 4.02 cm; HF: 7.86 +/-
176 in secondary outcomes were change in weight, waist circumference, lipids, serum glucose, and hemoglob
177 -0.02)] with the HOMA-IR in subjects with a waist circumference </=88 cm in women or </=102 cm in me
178 calorie-restricted diet for 6 wk to obtain a waist circumference <102 cm followed by a weight-mainten
179 Twenty-five healthy, normal-weight men (waist circumference: <94 cm) and 54 abdominally obese me
180 .80 kg (95% CI: -1.61, 0 kg), P = 0.05], and waist circumference [MD: -2.08 cm (95% CI: -3.97, -0.20
182 tio were calculated from weight, height, and waist circumference measurements whereas fat mass was as
183 Complete case sample sizes were 401 917 (waist circumference models), 401 435 (BMI), and 395 640
184 weight loss maintenance and changes in BMI, waist circumference, number of steps per day, health-rel
185 (odds ratio, 4.90; 95% CI, 1.06-22.63), and waist circumference (odds ratio, 1.24; 95% CI, 1.00-1.55
186 y obese men, dietary weight loss targeting a waist circumference of <102 cm improved retinal microvas
187 iglyceride level <1.3 mmol/L [<115.1 mg/dL], waist circumference of 85 cm [men] or 80 cm [women], and
188 d to examine the modifying effect of BMI and waist circumference on these associations among adults w
190 syndrome revealed associations for elevated waist circumference (OR 2.84, 95% CI 1.35 to 5.99) and e
191 le, body fat percentage, skinfold thickness, waist circumference, or prevalence of overweight or obes
192 adjustment for skin type, fracture history, waist circumference, outdoor free play, neighborhood inc
193 baseline levels and trajectories of BMI and waist circumference over time using linear mixed modelin
194 nd percentage of body fat from bioimpedance; waist circumference; overweight and obesity; height; BP;
198 3.3% vs. 17.1 in controls, p = 0.02), higher waist circumference (prevalence risk ratio 83.3/20.3, 4.
199 nomic disadvantage with fatty liver included waist circumference (proportion mediated of the total ef
200 Despite decades of unequivocal evidence that waist circumference provides both independent and additi
201 belt, intragastric pressure correlated with waist circumference (r = 0.682; P = .008), with the rang
202 oss was indifferent, exercise attenuated the waist circumference rebound with the greatest effect in
203 ciation was accounted for mostly by attained waist circumference (reduction of 61%) and by the biomar
204 sease history, and body mass index (BMI) and waist circumference; results were pooled based on a rand
206 s index (BMI): rg = 0.20, P = 3.12 x 10(-9); waist circumference: rg = 0.20, P = 2.12 x 10(-7)).
208 d on an algorithm including body mass index, waist circumference, serum gamma-glutamyltransferase and
209 study measured child body mass index (BMI), waist circumference, skinfold thickness, and body fat ma
210 ements (taken from birth through childhood), waist circumference, skinfold thickness, blood pressure,
211 After adjusting for age at enrollment, race, waist circumference standardized by body mass index, cur
213 ly less weight gain and smaller increases in waist circumference than olanzapine and was well tolerat
214 edicted by an interaction between height and waist circumference: the presumed benefits of being tall
215 n the knowledge, including the refinement of waist circumference threshold values for a given BMI cat
217 ed: 1) periodontitis; 2) body mass index; 3) waist circumference to height (WHTR) ratio for central a
218 , and inflammatory systems (body mass index; waist circumference; total, high and low density lipopro
219 combines measures of body mass index (BMI), waist circumference, triglyceride, and gamma-glutamyl tr
222 and natural log-transformed blood pressure, waist circumference, triglycerides, fasting glucose, and
223 was computed from the following components: waist circumference, triglycerides, HDL-c, glucose, and
224 dex, physical activity, body fat percentage, waist circumference, triglycerides, total cholesterol, a
225 ciated with blood pressure, body mass index, waist circumference, triglycerides, type-2 diabetes mell
226 these factors related to changes in BMI and waist circumference using econometric fixed-effects mode
228 ung cancer risk (for the highest category of waist circumference vs. the lowest, hazard ratio = 1.25,
229 ese three lncRNAs and body mass index (BMI), waist circumference, waist to hip ratio and fasting insu
230 work stress was associated with higher BMI, waist circumference, waist-hip ratio, alanine transamina
231 vely examined the effect of body mass index, waist circumference, waist-hip ratio, and 10-year weight
232 take have negative genetic correlations with waist circumference, waist-hip ratio, and neighborhood d
233 ith risk of T2DM, increased body mass index, waist circumference, waist-hip ratio, diastolic blood pr
234 and height, weight, body mass index, hip and waist circumference, waist-to-hip ratio, and bioelectric
235 hropometric measurements of body mass index, waist circumference, waist-to-hip ratio, and fat percent
236 ciations with measures of central adiposity (waist circumference, waist-to-hip ratio, and waist-to-he
237 F risk for 1-SD increases in epicardial fat, waist circumference, waist/hip ratio, and body mass inde
238 (2) = 26%, n = 3), and per 10 cm increase in waist circumference was 1.13 (95% CI 1.02-1.25, I(2) = 4
239 ummary relative risk for a 10-cm increase in waist circumference was 1.29 (95% confidence interval, 1
240 Mean body mass index was 30.8+/-7.1 kg/m(2), waist circumference was 102+/-17 cm, WHR was 0.91+/-0.08
242 rse association between MVPA and 6-y gain in waist circumference was also limited to the older group
243 95% bias-corrected CI: 0.94, 1.72), and when waist circumference was controlled for, the effect of bi
245 similar in both groups, but the reduction in waist circumference was higher in the MED/LC group (-6.9
247 that the genetic correlation between MDD and waist circumference was only significant in individuals
248 circumference (B = 1.59, P < 0.001), whereas waist circumference was positively associated with seden
250 associations were generally consistent when waist circumference was used as the measure of adiposity
251 found that central adiposity, as measured by waist circumference, was associated with worse global lo
252 de association studies of BMI (n = 681,275), waist circumference (WC) (n = 224,459) and waist-hip rat
253 c regression indicates each unit increase in waist circumference (WC) (OR 0.98, 95% CI 0.96-0.99) and
254 x (BMI) (SD) was 23.7 (3.3) kg/m(2) and mean waist circumference (WC) 80.3 (9.8) cm, with 33% having
256 ervals (CI) = -0.012; 0.002), p = 0.190], or waist circumference (WC) and sleep duration [(unstandard
257 sociated with abdominal obesity, measured by waist circumference (WC) and waist-hip ratio (WHR), have
259 ith obesity, using body mass index (BMI) and waist circumference (WC) as obesity indices in northeast
261 ation of a BMI of 18.5-23.9 kg/m(2) and 1) a waist circumference (WC) of >85 cm in males or >80 cm in
262 ine the association of birth weight (BW) and waist circumference (WC) on cardiovascular disease (CVD)
263 hanges in fat mass (FM), lean mass (LM), and waist circumference (WC) to the risk of HF and myocardia
264 GPRS-obesity) with body mass index (BMI) and waist circumference (WC) was modified by sleep character
267 e found that changes in body weight (BW) and waist circumference (WC) were significantly different ac
268 indices including body mass index (BMI) and waist circumference (WC) were used to determine general
269 the age- and sex-specific z-scores for BMI, waist circumference (WC), and blood pressure (BP) (n app
271 analysis of baseline body mass index (BMI), waist circumference (WC), and type II diabetes mellitus
273 esity-related traits [body mass index (BMI), waist circumference (WC), high-density lipoprotein (HDL)
274 However, except waist-to-hip ratio (WHR) and waist circumference (WC), it remains unknown whether the
275 t are associated with body mass index (BMI), waist circumference (WC), or the waist-to-hip ratio adju
277 istical analyses were body mass index (BMI), waist circumference (WC), serum adipokines, cytokines, a
280 rtension, and between body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR),
281 y outcomes were changes in body weight, BMI, waist circumference (WC), waist-to-height ratio (WtHR),
285 s index (kg/m2) >=25] and central adiposity [waist circumference (WC): >88 cm for women, >102 cm for
286 = 0.93; 95% confidence interval = 0.89-0.96; waist circumference (WC): OR per 10 cm = 0.81 (0.69-0.96
287 iet quality, and adiposity (body mass index, waist circumference, weight status, and central weight s
289 BMI in middle age, BMI at age 18 years, and waist circumference were associated with increased rheum
290 ters < 296 dB/m, BMI < 25 kg/m(2) and normal waist circumference were included in the interventional
298 lly attenuated after adjustments for BMI and waist circumference, which demonstrates a crucial role f
299 essure, total cholesterol, triglycerides and waist circumference with risk of meningioma were non-sig
300 Ox-LDL mediated 13.9% of the association of waist circumference with triglycerides and only 1-3% of